Previous Article | Next Article ![]()
Journal of Bacteriology, April 2006, p. 3052-3062, Vol. 188, No. 8
0021-9193/06/$08.00+0 doi:10.1128/JB.188.8.3052-3062.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Department of Molecular Biology, Umeå University, S-901 87 Umeå, Sweden
Received 11 November 2005/ Accepted 20 January 2006
|
|
|---|
|
|
|---|
![]() View larger version (30K): [in a new window] |
FIG. 1. Locations of thiolated nucleosides present in tRNA from S. enterica. s2C32, 2-thiocytidine; mnm5s2U34, 5-methylaminomethyl-2-thiouridine; cmnm5s2U34, 5-carboxymethylaminomethyl-2-thiouridine; s4U8, 4-thiouridine; ms2io6A37, N6-(4-hydroxyisopentenyl)-2-methylthioadenosine; ms2i6A37, N6-(isopentenyl)-2-thioadenosine. The numbers following the abbreviations of the modified nucleosides indicate the position in the tRNA.
|
The sulfur relay in the synthesis of thiolated nucleosides is summarized in Fig. 2. ThiI transfers sulfur directly from IscS to the target nucleoside (U8) in tRNA (19, 33). A similar sulfur transfer reaction was suggested for the synthesis of the s2 group of (c)mnm5s2U34 (mnm5s2U and cmnm5s2U), in which IscS transfers the sulfur to TusA, which in turn delivers it to TusD in the TusBCD complex. TusE may accept sulfur from TusD and deliver it to MnmA, which transfers it to U8 in tRNA (16, 21). Thus, in these two cases, the IscS persulfide donates its sulfur directly to a protein [ThiI in the synthesis of s4U8 and TusA in the case of (c)mnm5s2U34], and no [Fe-S] protein is thought to participate in the synthesis of these two thiolated nucleosides (designated the [Fe-S] protein-independent pathways). TtcA is required for the synthesis of s2C32 (17), and since it contains several cysteines it may be an [Fe-S] protein, which has recently been demonstrated (Marc Fontecave and Mohamed Atta [Grenoble, France], personal communication). The MiaB protein, which belongs to the SAM-radical family of enzymes, is an [Fe-S] protein (36), and apparently it can alone catalyze the formation of the ms2 group of ms2i(o)6A37 (ms2i6A and ms2io6A), albeit at a low efficiency (37). The presence of IscU, HscA, or Fdx is required in the synthesis of s2C32 and ms2i(o)6A37 but not in the synthesis of s4U8 and (c)mnm5s2U34 (26). Therefore, it was suggested that in the synthesis of s2C32 and ms2i(o)6A37, an [Fe-S] protein(s) participates. Thus, two distinct pathways for thiolation of tRNA exist. In the [Fe-S] protein-independent pathway, which is responsible for the synthesis of s4U8 and (c)mnm5s2U34 (pathway II in Fig. 2), there is a direct transfer of sulfur from IscS to a protein which in turn transfers the sulfur to the target nucleoside in tRNA for the synthesis of s4U or to another protein in the sulfur relay for the synthesis of (c)mnm5s2U. In the [Fe-S] protein-dependent pathway, which is responsible for the synthesis of s2C32 and ms2i(o)6A37 (pathway III in Fig. 2), an [Fe-S] protein(s) participates, and its formation and maintenance are dependent on IscS (26). In the latter two cases, the sulfur is transferred from IscS to IscU, and IscA, HscA, HscB, and Fdx participate in a complex way, not so far unraveled in detail, to form [Fe-S] cluster-loaded IscU, which then transfers the cluster to the receiving apoprotein (18) (Fig. 2). A lack of any of these participating proteins except IscA almost abolishes the synthesis of s2C32 and ms2io6A37. Apparently, to optimize the formation of ms2io6A, the presence of IscA is required, since the lack of it reduces the formation of only this thiolated nucleoside (26). Since this model of two distinct pathways in the thiolation of tRNA was based on the analysis of deletions of various genes involved in thiolation of tRNA, a more elaborate pathway may exist if proteins interact in a specific manner through various protein-protein complex formations. This paper addresses this question by analyzing mutants with point mutations in iscS selected for deficiency in the synthesis of one of the end products, (c)mnm5s2U34 or ms2i(o)6A37, of the two pathways. We found that some amino acid substitutions in IscS affected the synthesis of only a subset of the thiolated nucleosides, suggesting substrate specificity of IscS in the thiolation of tRNA (Fig. 2).
![]() View larger version (17K): [in a new window] |
FIG. 2. Sulfur trafficking in the synthesis of the thiolated nucleosides in S. enterica. The dotted arrows indicate uncertainties as to whether other proteins participate in sulfur mobilization, since the details of the transfer have not been established, whereas solid arrows indicate established pathways. Sulfur from Cys is transferred to IscS, creating a persulfide, and the sulfur is in turn moved to its various target proteins in the synthesis of s4U, (c)mnm5s2U (s2U), s2C, and ms2i(o)6A (ms2) (26). The synthesis of all thiolated nucleosides requires IscS, and mutants deficient in all thiolated nucleosides are designated class I mutants. In the synthesis of s4U and (c)mnm5s2U, sulfur is transferred directly from the persulfide present in IscS to a protein, which is ThiI in the synthesis of s4U or TusA in the synthesis of (c)mnm5s2U ([Fe-S] protein-independent pathway or pathway II). The arrow from IscS to ThiI represents the direct transfer of sulfur from IscS to ThiI (19, 20, 32), and the multistep arrow between IscS and MnmA shows the TusA-to-TusD/TusBC/TusE sulfur relay (16). Mutants defective in these pathways are designated class II mutants, mutants deficient only in s4U are class IIA, and those deficient only in mnm5s2U are class IIB. The synthesis of s2C and ms2i(o)6A depends on [Fe-S] cluster proteins, whose formation is dependent on proteins IscU, IscA, Fdx, HscA, and HscB (26) ([Fe-S]-dependent pathway or pathway III). Besides IscU, only IscA is shown, since its presence is required for efficient formation of only ms2i(o)6A, and this IscA-mediated stimulation may act by optimizing IscU[Fe-S] formation (arrow a) and/or by optimizing mature MiaB formation (arrow b). Mutants deficient in s2C and ms2i(o)6A are designated class III mutants. The mutants deficient only in s2C are class IIIA mutants, and those that are deficient only in ms2i(o)6A are class IIIB mutants.
|
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Salmonella enterica serovar Typhimurium strains
|
Genetic procedures. Transduction with phage P22 HT105/1 (int-201) (39) was performed as described previously (8). Mutagenesis was performed using overexpression of the DinB protein (22, 48) regulated by an araC promoter harbored on a plasmid kindly supplied by Dan Andersson, Uppsala, Sweden (28).
Isolation of mutants.
A crystal of nitrosoguanidine was placed on an LA rich agar plate seeded with strain GT6430 (STM2545-2525::Tn10dTc). The Tn10dTc insertion is only
2 kb away from the isc operon, and thus both the transposon and the isc operon can be present on the same DNA fragment of one P22 phage. After incubation overnight, a clear zone where no cells were growing appeared around the crystal. Cells from the area just outside the clear zone were collected, transferred to 1 ml of LB medium, and incubated for 2 h. Phage P22 was grown on such a culture and used to transduce either strain GT853 (hisC3737) or strain GT6942 (hisD10114). Five milliliters of overnight culture of the recipient cells was incubated with phage P22 for 30 min at 37°C. Cells were collected by centrifugation and washed twice with 0.9% NaCl containing 10 mM EGTA to remove unabsorbed phages before the culture was plated on selective plates. Tcr His+ transductants were selected on agar plates containing either medium E, 0.2% glucose, and 2.5 µg/ml tetracycline (Tc) or medium E, 0.2% glucose, thiamine, nicotinic acid, and 2.5 µg/ml Tc. Thiamine and nicotinic acid were included, since some mutations in iscS induce auxotrophy for these metabolites (24). Sometimes salt medium M9 (31) was used instead of medium E, with no discernible difference. The plates were incubated at 37°C for up to 7 days. The Tcr His+ transductants were purified on LA plates containing 10 mM EGTA. Phage P22 was grown on the purified transductants and backcrossed to the parent strain to obtain mutants, which did not contain mutations outside the isc region. The cross was performed on LA plates containing 15 µg/ml Tc and 10 mM EGTA, followed by replica printing on medium E plates containing 0.2% glucose with or without histidine. The cotransduction frequency between Tcr and His+ phenotypes was such that the His+ phenotype could be caused by a mutation in iscS (data not shown). One Tcr His+ transductant from each backcross was saved for further analysis. Mutational siblings were eliminated by comparing similarities in growth/suppression phenotype and/or high-pressure liquid chromatography (HPLC) analysis. Finally, mutant strains were complemented with the piscS plasmid, harboring only the wild-type allele of the iscS+ gene (41), and chromosomal sequencing of the iscS gene in the mutants was performed.
To isolate DinB-induced Tcr His+ mutants, an overnight culture of strain GT7172 (STM2545-2525::Tn10dTc/pSMP24; pSMP24 contains the dinB gene controlled by an arabinose promoter) (28) was diluted 1,000-fold in LB medium containing 0.2% arabinose and allowed to grow for 8 h, after which phage P22 was added to the culture and the phage-bacterium mixture was incubated overnight in a rotary shaker. The bacteria were removed by centrifugation, and the supernatant was treated with chloroform. Such phage stocks were used to select frameshift suppressors as described above.
DNA sequencing. Sequencing was performed on chromosomal DNA or PCR products as described in the manual for the Applied Biosystems ABI PRISM Cycle Sequencing Ready Reaction Big Dye Kit (Applied Biosystems, Foster City, California).
Analysis of modified nucleosides in tRNA. Bacterial strains were grown in LB medium (4) at 37°C to about 4 x 108 to 6 x 108 cells/ml. Cells were lysed, and total RNA was prepared (10). Total RNA was dissolved in buffer R200 (10 mM Tris-H3PO4, pH 6.3; 15% ethanol; 200 mM KCl) and applied to a Nucleobond column (AX500) equilibrated with the same buffer. tRNA was eluted with 7 ml of buffer R600 (R200 but containing 600 mM KCl), precipitated with 2.5 volumes of cold ethanol, washed twice with 80% ethanol, and dried. The dried tRNA was dissolved in water, and a portion of it was degraded to nucleosides by nuclease P1 followed by treatment with bacterial alkaline phosphatase (14). The hydrolysate was analyzed by HPLC (13) using a C18 HPLC column (250 by 4.6 mm; Phenomex Ltd., MacClesfield, Cheshire, United Kingdom).
Western blotting.
Total protein was prepared from cells grown to a cell density of
5 x 108 cells/ml in LB medium by sonicating the cells using a VCX400 Vibracell sonicator (Sonics Inc). The cell debris was removed by centrifugation at 3,000 x g for 10 min. The supernatant was diluted with 1 ml of water, total protein was determined using a protein assay kit (Bio-Rad Inc., Hercules, California), and 25 µg was applied in each well on a 12% sodium dodecyl sulfate-polyacrylamide gel. Proteins were separated using the Mini-Protean II protein electrophoresis system (Bio-Rad Inc., Hercules, California). Two gels were used in parallel experiments, with equal amounts of proteins from the same preparation applied on each gel. One gel was used for TrmD as a control and the other for IscS determinations. Proteins were blotted to Amersham Hybond C membranes using the wet blot transfer system Mini Trans blot cell (Bio-Rad Inc.). Blocking was performed with the ECL blocking agent (Amersham Life Sciences, GE Healthcare, Uppsala, Sweden). Primary antibodies against IscS, kindly provided by Larry E. Vickery (Irvine, California), and TrmD (27) were added, followed by incubation with the secondary antibody according to the protocol supplied with the ECL Plus kit (Amersham Life Sciences, GE Healthcare, Uppsala, Sweden). ECL detection was performed in a Fluor-S Max2 Lumi-imager (Bio-Rad Inc., Hercules, California).
|
|
|---|
![]() View larger version (42K): [in a new window] |
FIG. 3. Working model showing how modification deficiency influences reading frame maintenance at the frameshifting sites -CCC-CAA-UAA (A) and -UUU-UAU-UAA (B). (A) At a low frequency the near-cognate tRNAcmo5UGGPro (V = cmo5U) enters the A site and binds to the CCC codon at the expense of binding of the cognate tRNAGGGPro. Following a normal three-nucleotide translocation, it is residing in the P site as peptidyl-tRNAcmo5UGGPro. If the tRNAcmnm5s2UUGGln is deficient in, e.g., cmnm5s2U34, the ribosome stalls due to slow entry of the ternary complex containing the defective tRNA or low concentration of the ternary complex, thereby allowing the peptidyl-tRNAcmo5UGGPro to slip forward one nucleotide, and the ribosome can continue in the zero frame. (B) Since ms2i(o)6A37 is present in both tRNAGAAPhe and tRNAQUATyr, deficiency in this modification can induce frameshifting in two ways. Since tRNAGAAPhe increases a P-site slippage only when lacking ms2i(o)6A37 and deficiency of the same modification in tRNAQUATyr may cause a pause, the combined deficiency of this modification in these tRNAs will mediate frameshifting by tRNAGAAPhe slippage in the P site. Alternatively, ms2i(o)6A37 deficiency of tRNAQUATyr might also mediate P-site slippage when the ribosome pauses at the stop codon UAA.
|
To test our strategy, we introduced mutations in mnmA or miaB, which encode thiolating enzymes required for the synthesis of (c)mnm5s2U34 and ms2io6A37, respectively, into strains with one of the two different frameshifts sites hisC3737 and hisD10114. Whereas the mnmA1 mutation suppressed only the hisC3737 (CCC-CAA-UAA) mutation, the miaB1 mutation suppressed only the hisD10114 (UUU-UAU-UAA) mutation (data not shown). Thus, we anticipated that iscS mutations suppressing hisC3737 would concomitantly cause deficiency in at least (c)mnm5s2U34, whereas iscS mutations suppressing hisD10114 would cause deficiency in at least ms2i(o)6A37. Since mutations in thiI or ttcA, whose products are required for the synthesis of s4U8 and s2C32 on the tRNA, respectively, did not suppress any of these two +1 frameshift mutations (data not shown), we did not anticipate obtaining iscS mutants deficient in only either of these thiolated nucleosides. Thus, suppression of the two frameshift mutations hisC3737 and hisD10114 requires deficiency of only (c)mnm5s2U34 and only ms2i(o)6A37, respectively.
Isolation, identification, and characterization of iscS mutations found to cause defects in either of the two tRNA thiolation pathways. Strain GT6430, which has a Tn10dTc inserted just upstream of the isc operon, was mutagenized either by DinB overexpression or by treatment with nitrosoguanidine. Phage P22 was grown on such mutagenized cultures and used to infect strain GT853 (hisC3737; CCC-CAA-UAA) or strain GT6942 (hisD10114; UUU-UAU-UAA). Tcr His+ transductants were selected and backcrossed to the original parent strains to avoid mutants with compensatory mutations in the his operon. However, the frequency of such mutations ought to be low, since the his operon is located far from the isc operon. This approach should also avoid any mutations in the structural genes whose products are required for the synthesis of thiolated nucleosides, such as thiI (s4U8), mnmA [(c)mnm5s2U34], or miaB [ms2i(o)6A37], since their chromosomal locations are far from the isc operon. The mutations in the various His+ mutants characterized were all located in the iscS gene, since cotransduction frequencies between the Tcr and His+ phenotypes were such that the His+ phenotype could be caused by a mutation in iscS and since introduction of a plasmid carrying the wild-type allele of iscS complemented the mutant phenotypes (His+ and the deficiency in thiolation of tRNA) (Tables 2 and 3). The mutations were identified by sequencing of the iscS genes from the various mutants. Thus, the induced phenotype must be caused by the alteration in IscS. tRNA was isolated and degraded to nucleosides, and the distribution and quantification of nucleosides were determined by HPLC (Fig. 4; Tables 2 and 3).
|
View this table: [in a new window] |
TABLE 2. Mutations in iscS that mediate suppression of the frameshift mutation hisC3737 (CCC-CAA)
|
|
View this table: [in a new window] |
TABLE 3. Mutations in iscS that mediate suppression of the frameshift mutation hisD10114 (UUU-UAU-UAA)
|
![]() View larger version (26K): [in a new window] |
FIG. 4. Panels A and B show elution time in the region from 9.5 to 29 min, while panels C and D show that in the region from 48 to 86 min, of tRNA hydrolysate from strains GT6942 (iscS+) (A and C) and GT7153 (iscS59) (B and D). The eluate was monitored at 254 nm. The various thiolated nucleosides are indicated. AU, absorbance units at 254 nm.
|
One suppressor mutation, iscS58, of the hisD10114 (UUU-UAU-UAA) mutation was deficient in all thiolated nucleosides (Table 3). However, by using this frameshifting site we also obtained mutants defective in the synthesis of one or more of the thiolated nucleosides, such as the class IIIB mutants carrying iscS63, -65, and -66 [deficient in only ms2i(o)6A] and iscS64 [deficient in all thiolated nucleosides except (c)mnm5s2U34] (a class IIA and III mutant) (Table 2). The iscS65 and -66 mutants had a phenotype reminiscent of that of a mutant deleted for iscA, which is also deficient in only ms2i(o)6A37 (26). Note also that the iscS65 and -66 mutations, as well as deletion of iscA, reduced ms2i(o)6A to a similar level (about 50% of the wild-type level). However, the iscS65 and -66 mutants have a wild-type allele of the iscA gene as determined by DNA sequencing (data not shown), and these mutants had only a mutation in the iscS gene, because the wild-type phenotype was restored by introducing the wild-type allele of iscS+ on a plasmid (Table 3). Both mutants contained an alteration in the C-terminal part of the IscS protein. The iscS66 mutation was a frameshift mutation in codon 380 resulting in a truncated IscS. The iscS65 mutation changed His350 to Arg350.
Some amino acid substitutions may reduce the stability of the IscS protein, which would result in a lower activity in the cell and thereby lower synthesis of all thiolated nucleosides. We therefore monitored the levels of the IscS protein in the various mutants (Fig. 5). The levels of full-size IscS in the iscS56 and -58 mutants were significantly lower than that in the wild type, and, accordingly, these mutations reduced the levels of all thiolated nucleosides (Tables 2 and 3; Fig. 5). All other mutations did not reduce the level of IscS, which is why the phenotype mediated by these mutations must be caused by the activity of IscS and not by a lower level of the protein. The isc operon is controlled by IscR, which senses the [Fe-S] status of the cell (40). Thus, a nonfunctional IscS, which should decrease the [Fe-S] content of the cell, ought to derepress the isc operon, as was observed for some mutants (the iscS55, iscS57, iscS59, and iscS60 mutants) (Fig. 5).
|
View larger version (24K): [in a new window] |
FIG. 5. Levels of IscS as determined by Western blotting. The upper set of bands is from blotting with TrmD antibody, and the lower set of bands is from blotting with IscS antibody. Levels of IscS were normalized against TrmD and then divided by the wild-type levels of IscS as shown below. Values shown are the averages and ranges from two independent experiments. Mutants with a significantly reduced level of IscS are shown in boldface.
|
|
View this table: [in a new window] |
TABLE 4. Summary of phenotypes of mutants isolated as suppressors to the frameshift mutation hisC3737 (CCC-CAA-UAA) or hisD10114 (UUU-UAU-UAA)
|
|
|
|---|
The selection of the mutants and analysis of the thiolation level of the tRNA were done with the iscS+ gene present at its wild-type location on the chromosome. Thus, potential multicopy artifacts, which may be introduced if the IscS protein is encoded from a plasmid, or regulatory artifacts caused by misplacement of the iscS gene on the chromosome were avoided. Therefore, we believe that our results obtained from the analyses of the various mutants are true reflections of the in vivo kinetics of the synthesis of the thiolated nucleosides and thus a reflection of the efficiency of sulfur transfer and of synthesis and maintenance of [Fe-S] cluster proteins participating in the thiolation of tRNA.
Deletion of the iscS gene abolishes the synthesis of all thiolated nucleosides (23). Since iscS58 is a frameshift mutation early in the iscS gene (Table 4), we expected that this mutation also should mediate a similar phenotype. However, this was not the case, since this mutant still had significant residual levels of all thiolated nucleosides (Table 3) and, accordingly, a low level of full-size IscS was observed (Fig. 5). The explanation might be that the deficiencies of both (c)mnm5s2U34 and ms2i(o)6A37 in this mutant also mediate suppression of the iscS58 frameshift mutation per se by hypomodified tRNA(s) resulting in a small level of active IscS protein. Since the iscS mRNA might also be overexpressed because of a nonfunctional IscR (40), the level of a possible frameshift product of IscS would be elevated, explaining the observed phenotypes (Table 3; Fig. 5). There are several codons in the frameshifting window created by the iscS58 mutation that would potentially be suppressed by these hypomodified tRNAs.
Five mutations, i.e., iscS51, -56, -58, -60, and -61, reduced the synthesis of all thiolated nucleosides (Tables 2, 3, and 4). For the iscS56 and -58 mutants the low levels of all thiolated nucleosides are explained by the apparent instability of the IscS protein in these mutants (Fig. 5). The iscS51 (A327V) mutation results in an amino acid substitution next to the catalytic Cys328 present in the active-site loop region. The iscS51 mutation, which does not affect the stability of IscS (Fig. 5), abolishes the synthesis of all thiolated nucleosides (34). The phenotype caused by the A327V substitution is likely due to an activity change due to its close proximity to the catalytic Cys328. The A327V substitution might change the flexibility of the active loop (25, 45), resulting in a conformational change in the neighborhood of the catalytic Cys328 that gives a lower desulfurase activity. The iscS61 (M169V) mutation, which, like iscS51, does not affect the stability of IscS (Fig. 5), also results in a deficiency of all thiolated nucleosides, and it is located far from the catalytic Cys328 (Table 4). Therefore, we suggest that the M169V alteration influences the desulfurase activity in a way similar to that of the iscS51 mutation and not by affecting the stability of IscS. A mutation (iscS63) resulting in an alteration (V153W) rather close to the iscS61 (M169V) mutation did not reduce the levels of all thiolated nucleosides as the latter mutation did, and, accordingly, the level of IscS was not reduced (Tables 3 and 4; Fig. 5). The V153W alteration only slightly affected the [Fe-S] protein-dependent pathway [ms2i(o)6A] (Table 3), indicating that the synthesis of this thiolated nucleoside is especially sensitive to small aberrations in the desulfurase activity and/or iron mobilization.
Lauhon et al. (25) generated IscS mutants by alanine scanning mutagenesis from amino acid Ser323 to amino acid Ser336 in the active-site loop. Indeed, a C328A alteration abolishes the synthesis of all thiolated nucleosides, consistent with the suggested pivotal role of Cys328 in the function of IscS. Of the other 13 alterations, 11 did not influence the thiolation of tRNA, and the two alterations (S326A and L333A) which influence thiolation of tRNA do so in a specific way, since they reduce the synthesis of only s2C32 and ms2i6A37; i.e., they affect only the [Fe-S] protein-dependent pathway (class III mutants). Note that the Ser326 is part of the consensus sequence (S323-GS326AC328- - - - - -PS-VL339; the conserved amino acids are shown and dashes indicate nonconserved amino acids) and that it is only two amino acids away from the catalytic Cys328 and only one amino acid away from the conserved A327, which when replaced by Val reduces the synthesis of all thiolated nucleosides (34). A replacement of the nonconserved Ala by Ser (iscS64) at position 321 resulted in a complex phenotype (Table 2 and 4). Whereas the S326A and L333A alterations of IscS do not decrease the cysteine desulfurase activity (25), the A321S change does (class IIB mutant) (Table 3 and 4), as demonstrated by the reduced synthesis of s4U8, which is dependent on a desulfurase activity and not on any [Fe-S] protein (26). Thus, amino acid substitutions in the active loop and near the catalytic Cys328 induce multiple phenotypes: (i) no change in tRNA thiolation (S323, S324, G325, T329, S330, S332, E334, P335, and S336 to Ala) (25), (ii) deficiency in s2C32 and ms2i(o)6A37 (class III mutants; S326A and L333A) (25), (iii) deficiency in all thiolated nucleosides (class I mutants; A327V) (34) (Table 4), or (iv) deficiency in s4U8, s2C32, and ms2i(o)6A37(class IIB and III; A321V) (Table 4). Apparently, alterations in the vicinity of the active site have different impacts on the activity and/or the substrate specificity of IscS.
We also obtained mutants (iscS55, -57, and -59) with decreased levels of s4U8 and (c)mnm5s2U34 (iscS55 and -57) or of only (c)mnm5s2U34 (iscS59). Thus, these mutants have normal levels of s2C32 and ms2i(o)6A37, whose synthesis is dependent on [Fe-S] proteins. The alterations in the iscS55 and -57 mutants (W45R and V65F, respectively) are located far from the catalytic Cys328 and are clustered in the N-terminal
-helix (Fig. 6). The [Fe-S] protein-dependent pathway seems to be intact in these mutants, implying that the activity of the altered IscS proteins is sufficient for the synthesis of s2C and ms2i(o)6A. However, the levels of IscS were increased (Fig. 5), suggesting that other [Fe-S] proteins not involved in the thiolation of tRNA are affected, giving rise to derepression of iscS. Since W45 and D65 are exposed on the surface of IscS and are far from the catalytic Cys328 (Fig. 6), they may interact with TusA and ThiI, which both receive sulfur from IscS (16, 19), although long-range conformational changes around the catalytic Cys328 cannot be excluded. The H96Y alteration, as in the iscS59 mutant, results in a decreased level of only (c)mnm5s2U34 (class IIB mutant) and is also exposed on the surface of IscS but is located rather far from the other two class II alterations (Fig. 6). The level of IscS in the iscS59 (H96Y) mutant was slightly elevated compared to that in the wild type (Fig. 5), and the mutant possesses desulfurase activity (makes s4U8). Therefore, the H96Y alteration seems to have a negative impact on the IscS-TusA interaction but not on the overall desulferase activity. We suggest that the surface composed of the N-terminal
-helix of IscS, where the W45R and D65Y mutations are located, as well as the surface where H96Y is located, may make protein-protein contacts with the acceptor proteins ThiI and MnmA, which are required for the synthesis of s4U8 and (c)mnm5s2U34 ([Fe-S]-independent pathways).
![]() View larger version (62K): [in a new window] |
FIG. 6. The three-dimensional structure of the E. coli IscS monomer (7) visualized with the Protein Explorer imaging program (29), v2.45 Beta (http://proteinexplorer.org). The file used is the Protein Data Bank (PDB) file 1P3W. The upper panel shows the locations of the C-terminal alteration H350R (iscS65, green) close to the catalytic Cys328 (marked with Ala327, yellow) and the C-terminal frameshift mutation at codon 380 (iscS66, blue) resulting in a 5-amino-acid truncation of IscS. The C terminus (pink), the N terminus (orange), and the cofactor pyridoxal-phospate (PLP) (brown) are also shown. The lower panel shows the locations of the W45R (iscS55, magenta) and D65Y (iscS57, red) amino acid substitutions on the same surface of IscS, which are distantly located from the active site (yellow). The H96Y (iscS59, cyan) alteration is also shown, and it is distant from W45 and D65 as well as separated from the active site (yellow).
|
376-404) is still active, since it complements the reduced growth induced by a deletion of iscS (45), suggesting that it synthesizes (c)mnm5s2U34, which is vital for efficient growth (Table 4). In vitro IscS
376-404 binds to IscU less well than the wild-type IscS and has a reduced [Fe-S] cluster formation activity but has a desulfurase activity similar to that of the full-length protein. Thus, apparently the C-terminally mediated binding to IscU is pivotal in [Fe-S] cluster formation. A prediction would therefore be that this mutant should be a class III mutant reducing the levels of s2C and ms2i(o)6A, i.e., influencing mainly the [Fe-S] protein-dependent pathway. Although the mechanism of how iron is delivered in the [Fe-S] cluster assembly is not known in detail, a direct role of IscA has been suggested (9). Whereas the absence of IscU abolishes the synthesis of both s2C and ms2i(o)6A ([Fe-S] protein-dependent pathways), the absence of IscA decreases the level of only ms2i(o)6A and by only 50% (26). Interestingly, our iscS65 and -66 mutants, which have IscS proteins with altered C termini, show a phenotype similar to that shown by a mutant lacking IscA (Table 3). Whereas the iscS65 mutation (H350A) is just upstream of the end of IscS
376-404, the iscS66 mutation is a frameshift change at codon 380 within the part of IscS that is absent in the IscS
376-404 mutant. A complete lack of IscA, an IscS with an H350S amino acid substitution, or an IscS with a completely different C terminus results in a similar twofold reduction in the level of ms2i(o)6A. Unless this similar reduction in the ability to form ms2i(o)6A is coincidental, it would suggest a role for the C-terminal part of IscS in a potential interaction with IscA. However, no stable complex between IscS and IscA has been established (44). Moreover, the iscS63 (V153W) mutation also slightly reduced the synthesis of ms2i(o)6A (Table 3), although this mutation is not located in the C-terminal end of IscS. Therefore, the reduction of the synthesis of only ms2i(o)6A by the mutations iscS63, -65, and -66 may suggest that the formation of the ms2 group of ms2i(o)6A37 is especially sensitive to minor aberrations in the formation or repair of the [Fe-S] cluster required to form this nucleoside. IscA may stimulate this reaction by optimizing the formation of mature IscU, since its presence increases by twofold the level of only ms2i(o)6A (26) (Fig. 2) and/or it may stimulate the formation of mature MiaB (Fig. 2). These results show that IscS has a complex substrate specificity revealed by alterations in different regions distinct from the catalytic region. They further suggest that IscS-dependent sulfur delivery and IscA-mediated [Fe-S] cluster formation is target specific. One could envision that several proteins compete for surfaces on IscS and such specific protein-protein interactions result in specific sulfur and/or iron mobilization. Some of the phenotypes caused by the mutations characterized in this study are consistent with such a hypothesis. Clearly, a quite complex set of interactions are involved in the sulfur trafficking required for the formation of the thiolated nucleosides on tRNA in S. enterica.
We thank Kristina Nilsson, who isolated the iscS55 mutant, and we thank Kerstin Jacobsson for the HPLC analysis. We thank Dan Andersson, Uppsala University, Sweden, for the gift of plasmid pSMP24 and Diana Downs, University of Wisconsin, Madison, for the gift of plasmid piscS. We are grateful for the generous gift of antibodies to IscS from Larry E. Vickery, University of California, Irvine. We also thank Tord Hagervall, Anders Byström, and Mikael Wikström for critical reading of the manuscript.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»